CELF2 is a candidate prognostic and immunotherapy biomarker in triple‐negative breast cancer and lung squamous cell carcinoma: A pan‐cancer analysis

CUGBP Elav‐like family member 2(CELF2) plays crucial roles in the development and activation of T cell. However, the impacts of CELF2 on tumour‐infiltrating immune cells (TIICs) and clinical outcomes of tumours remain unclear. In this study, we found that elevated CELF2 expression was markedly corre...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Libo, Liu, Zaoqu, Liu, Long, Guo, Chunguang, Jiao, Dechao, Li, Lifeng, Zhao, Jie, Han, Xinwei, Sun, Yuling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335674/
https://www.ncbi.nlm.nih.gov/pubmed/34288370
http://dx.doi.org/10.1111/jcmm.16791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335674/
https://www.ncbi.nlm.nih.gov/pubmed/34288370
http://dx.doi.org/10.1111/jcmm.16791

Ejemplares similares